Bregje Mol

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 356 citations

Medicine, Clinical Sciences, Surgery +12

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 179 citations

Medicine, Surgery, Gastroenterology +10

Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C Trial

E. Joline de Groof, Toer Stevens, Emma J. Eshuis et al. · Gut · 2019 · 103 citations · Full text

Pharmacy, Pharmacoeconomics, Surgery +16

Fertility after conservative and radical surgery for tubal pregnancy

Bregje Mol, H. C. Matthijsse, Dick J. Tinga et al. · Human Reproduction · 1998 · 91 citations · Full text

Medicine, Gynecology, Surgery +10

Disease burden in primary sclerosing cholangitis in the Netherlands: A long‐term follow‐up study

Kim N. van Munster, Bregje Mol, Jorn Goet et al. · Liver International · 2022 · 20 citations · Full text

Medicine, Internal Medicine, Gastroenterology +16